Neoral
® (
cyclosporine) is a prescription medication approved to treat severe
psoriasis and severe, active
rheumatoid arthritis in people who do not adequately respond to other treatments. It is also approved to prevent organ rejection after a kidney, liver, or heart transplant.
Neoral contains a modified form of cyclosporine, an immunosuppressant that is also found in
Sandimmune®. This modified form of cyclosporine has been slightly altered so that it is more easily absorbed by the body. Because
modified cyclosporine is absorbed differently than original cyclosporine, the medications cannot be directly substituted for each other.
Neoral is made by Novartis Pharmaceuticals Corporation.
Neoral is an immunosuppressant medication, which means it suppresses the immune system (makes it less active).
An overactive immune system is involved in rheumatoid
arthritis and psoriasis. Transplant rejection occurs when the body's immune system recognizes the transplanted organ as a foreign material and attacks it. By suppressing the immune system, Neoral can help prevent transplant rejection and ease symptoms of rheumatoid arthritis and psoriasis.
HealthSavvy Sign In
|
